Methicillin-resistant Staphylococcus aureus:: an increasing problem in a diabetic foot clinic

被引:149
作者
Tentolouris, N [1 ]
Jude, EB [1 ]
Smirnof, I [1 ]
Knowles, EA [1 ]
Boulton, AJM [1 ]
机构
[1] Diabet Foot Clin, Manchester, Lancs, England
关键词
diabetes mellitus; foot ulceration; infections; MRSA;
D O I
10.1046/j.1464-5491.1999.00132.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To study the prevalence of pathogenic organisms and the prevalence and outcome of methicillin-resistant Staphylococcus aureus (MRSA) infection in foot ulcers in diabetic patients. Methods A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients, selected from an outpatient diabetic foot clinic. Seventy-five patients (79 ulcers) with positive wound swabs were included. Size of ulcer and time to healing, in particular for MRSA-infected ulcers, were measured in all patients. Results Gram-positive aerobic bacteria were the commonest micro-organism isolated (56.7%) followed by Gram-negative aerobic bacteria and anaerobes (29.8% and 13.5%, respectively). Of the Gram-positive aerobes, S. aureus was found most frequently and 40% were MRSA. MRSA was isolated more commonly in patients treated with antibiotics prior to the swab compared to those who had not received antibiotics (P=0.01). Patients whose foot ulcers were infected by MRSA had longer healing time than patients whose ulcers were infected by methicillin-sensitive S. aureus (mean (range) 35.4 (19-64) and 17.8 (8-24) weeks, respectively, P=0.03). Conclusion MRSA infection is common in diabetic foot ulcers and is associated with previous antibiotic treatment and prolonged time to healing. Further studies are required to assess the need for antibiotics in treating foot ulcers in diabetes and to assess the optimum therapeutic approach to this problem.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 32 条
[1]   Report calls for action on antibiotic resistance [J].
Abbasi, K .
BRITISH MEDICAL JOURNAL, 1998, 316 (7140) :1261-1261
[2]   Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration [J].
Abbott, CA ;
Vileikyte, L ;
Williamson, S ;
Carrington, AL ;
Boulton, AJM .
DIABETES CARE, 1998, 21 (07) :1071-1075
[3]  
BENTKOVER JD, 1993, WOUNDS, V5, P207
[4]   ASSESSMENT AND MANAGEMENT OF FOOT DISEASE IN PATIENTS WITH DIABETES [J].
CAPUTO, GM ;
CAVANAGH, PR ;
ULBRECHT, JS ;
GIBBONS, GW ;
KARCHMER, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (13) :854-860
[5]  
Chantelau E, 1996, DIABETIC MED, V13, P156, DOI 10.1002/(SICI)1096-9136(199602)13:2<156::AID-DIA59>3.0.CO
[6]  
2-U
[7]  
DOEBBELING BN, 1995, J CHEMOTHERAPY, V7, P99
[8]  
EDMONDS ME, 1994, DIABETIC FOOT, P109
[9]  
FOSTER A, 1998, DIABETIC MED, V15, pA27
[10]  
GIBBONS GW, 1995, MANAGEMENT DIABETIC, P121